|
RRN3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.503200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.293800E-01 |
| Normal-vs-Stage2 |
5.558200E-01 |
| Normal-vs-Stage3 |
5.652000E-01 |
| Normal-vs-Stage4 |
4.159000E-01 |
| Stage1-vs-Stage2 |
6.291200E-01 |
| Stage1-vs-Stage3 |
6.360800E-01 |
| Stage1-vs-Stage4 |
4.558000E-01 |
| Stage2-vs-Stage3 |
9.455600E-01 |
| Stage2-vs-Stage4 |
8.464600E-01 |
| Stage3-vs-Stage4 |
7.670400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.133000E-01 |
| Normal-vs-AfricanAmerican |
2.244800E-01 |
| Normal-vs-Asian |
5.197400E-01 |
| Caucasian-vs-AfricanAmerican |
3.811600E-01 |
| Caucasian-vs-Asian |
5.192400E-01 |
| AfricanAmerican-vs-Asian |
2.713600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.803800E-01 |
| Normal-vs-Female |
7.280200E-01 |
| Male-vs-Female |
8.923600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.034400E-02 |
| Normal-vs-Age(41-60Yrs) |
8.568600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.715000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.220580E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.259590E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.742580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.070000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.671400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.953790E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.545800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.303800E-01 |
| Normal-vs-Grade 2 |
6.344400E-01 |
| Normal-vs-Grade 3 |
1.743360E-01 |
| Normal-vs-Grade 4 |
2.087200E-01 |
| Grade 1-vs-Grade 2 |
9.088800E-01 |
| Grade 1-vs-Grade 3 |
4.558000E-01 |
| Grade 1-vs-Grade 4 |
4.520800E-01 |
| Grade 2-vs-Grade 3 |
3.089900E-02 |
| Grade 2-vs-Grade 4 |
7.242000E-02 |
| Grade 3-vs-Grade 4 |
8.914600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.004800E-01 |
| Normal-vs-ccB subtype |
4.089400E-01 |
| ccA subtype-vs-ccB subtype |
1.826310E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.013400E-01 |
| Normal-vs-N1 |
6.751800E-01 |
| N0-vs-N1 |
5.707800E-01 |
|
|
